For instance, miR-101 overexpression considerably inhibits CCA cell proliferation and angiogenesis by targeting vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2) [108], and E2F8 [109]. Here, PTGS2 is linked to cholangiocarcinoma.